Neuro-Pro T007
NDC 71742-0001, Gaba, L-Dopa, Norepinephrine, Serotonin, Adrenocorticotrophin, Anacardium Orientale, Arsenicum Album, Baryta Carbonica, Calcarea Carbonica, Calcarea Phosphorica, Hyoscyamus Niger, Lycopodium Clavatum, Stramonium, liquid, from Guangzhou Renuma Medical Systems Co., Ltd.
- Product NDC
- 71742-0001
- Status
- Listed
- Labeler
- Guangzhou Renuma Medical Systems Co., Ltd
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71742-0001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- .GAMMA.-AMINOBUTYRIC ACID6 [hp_X]/mL
- LEVODOPA6 [hp_X]/mL
- NOREPINEPHRINE6 [hp_X]/mL
- SEROTONIN HYDROCHLORIDE6 [hp_X]/mL
- CORTICOTROPIN8 [hp_X]/mL
- ANACARDIUM OCCIDENTALE FRUIT30 [hp_C]/mL
- ARSENIC TRIOXIDE30 [hp_C]/mL
- BARIUM CARBONATE30 [hp_C]/mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE30 [hp_C]/mL
- TRIBASIC CALCIUM PHOSPHATE30 [hp_C]/mL
- HYOSCYAMUS NIGER30 [hp_C]/mL
- LYCOPODIUM CLAVATUM SPORE30 [hp_C]/mL
- DATURA STRAMONIUM30 [hp_C]/mL
Pharmacologic classes
Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Amino Acids, Aromatic [CS]; Aromatic Amino Acid [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71742-0001-1 | 71742000101 | 59 mL in 1 BOTTLE, DROPPER (71742-0001-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 71742-0001 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71742-0001 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71742-0001. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.